FindTrial
Sign In

The efficacy and safety effects of umbilical cord stem cells on male patients with late-onset hypogonadism: a single-centered, randomized, double-blind and placebo-controlled trial

Innovative strategies and application of stem cell transplantation in the treatment of typical immune diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018738
Enrollment
Unknown
Registered
2018-10-07
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related erectile dysfunction

Interventions

Group 1:give the cord blood stem cell by intravenous infusions
Group 2:give the placebo by intravenous infusions

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40 to 60 years old, male; 2. Erectile dysfunction and decreased libido for more than 3 months; 3. Having a sex mate.

Exclusion criteria

Exclusion criteria: 1. ALT 2.5 times larger than ULR or TBIL is 1.5 times larger than ULR; 2. serum creatinine > 133 mol/L; 3. HBA1c =9%; 4. A family history or past or present history of a malignant tumor; 5. Allergic constitution;A history of mental illness and drug or alcohol abuse; 6. Unstable cardiovascular and cerebrovascular diseases existed within 3 months; 7. Participated in other clinical trials within 3 months; 8. Taking phosphodiesterase inhibitors or other drugs to improve sexual function within 3 months.

Design outcomes

Primary

MeasureTime frame
Erectile function scale;—

Countries

China

Contacts

Public ContactJi Hongmei

Jimo District Chinese Traditional Medicine Hosptial

jihongmei1234@sina.com+86 18653260766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026